Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122096204 | 12209620 | 4 | F | 20151230 | 20160627 | 20160325 | 20160706 | EXP | JP-009507513-1603JPN008979 | MERCK | 71.00 | YR | M | Y | 77.00000 | KG | 20160706 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122096204 | 12209620 | 1 | PS | REBETOL | RIBAVIRIN | 1 | Oral | DAILY DOSAGE UNKNOWN | Y | 20903 | CAPSULE | ||||||||
| 122096204 | 12209620 | 2 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | 400 MG, INTERVAL 1 DAY (DEVIDED DOSAGE FREQUENCY REPORTED AS UNKNOWN) | 28000 | MG | Y | 0 | 400 | MG | TABLET | QD | |||
| 122096204 | 12209620 | 3 | SS | FEBURIC | FEBUXOSTAT | 1 | Oral | 10 MG, INTERVAL 1 DAY (DEVIDED DOSAGE FREQUENCY REPORTED AS UNKNOWN) | 1320 | MG | Y | 0 | 10 | MG | TABLET | QD | |||
| 122096204 | 12209620 | 4 | SS | DIART | AZOSEMIDE | 1 | Oral | 30 MG, INTERVAL 1 DAY (DEVIDED DOSAGE FREQUENCY REPORTED AS UNKNOWN) | 1320 | MG | Y | 0 | 30 | MG | TABLET | QD | |||
| 122096204 | 12209620 | 5 | SS | ALDACTONE A | SPIRONOLACTONE | 1 | Oral | 25 MG, INTERVAL 1 DAY (DEVIDED DOSAGE FREQUENCY REPORTED AS UNKNOWN) | 1100 | MG | Y | 0 | 25 | MG | TABLET | QD | |||
| 122096204 | 12209620 | 6 | C | AMINOLEBAN EN | UNSPECIFIED INGREDIENT | 1 | Oral | 50 G, QD, DIVIDED DOSE FREQUENCY UNKNOWN | U | 0 | 50 | G | POWDER | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122096204 | 12209620 | 1 | Hepatic cirrhosis |
| 122096204 | 12209620 | 2 | Hepatic cirrhosis |
| 122096204 | 12209620 | 3 | Hyperuricaemia |
| 122096204 | 12209620 | 4 | Oedema |
| 122096204 | 12209620 | 5 | Oedema |
| 122096204 | 12209620 | 6 | Hepatic cirrhosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122096204 | 12209620 | HO |
| 122096204 | 12209620 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122096204 | 12209620 | Hepatic encephalopathy | |
| 122096204 | 12209620 | Hepatic function abnormal | |
| 122096204 | 12209620 | Nausea | |
| 122096204 | 12209620 | Oedema | |
| 122096204 | 12209620 | Renal impairment | |
| 122096204 | 12209620 | Tinnitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122096204 | 12209620 | 1 | 20151118 | 20160129 | 0 | |
| 122096204 | 12209620 | 2 | 20151118 | 20160129 | 0 | |
| 122096204 | 12209620 | 3 | 20150917 | 20160218 | 0 | |
| 122096204 | 12209620 | 4 | 20151214 | 20160129 | 0 | |
| 122096204 | 12209620 | 5 | 20151214 | 20160129 | 0 | |
| 122096204 | 12209620 | 6 | 20160107 | 0 |